Mylan Hit With $69.2M In Treble Damages
Jan 25, 2008
All Content Copyright 2007, Portfolio Media, Inc.
Blue Cross Blue Shield of Massachusetts and three other health insurance firms that opted out of a $35 million class-action settlement against Mylan Laboratories Inc. to pursue their own antitrust allegations have won a whopping $69.2 million award in treble damages.
Click on the link below to read the full article.
Mylan Hit With $69.2M In Treble DamagesPDF compatible software, such as Adobe's Acrobat Reader, is required to read this document. You may download a free copy of Adobe's Acrobat Reader or view a list of other PDF software.
Related Links